missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human Prostatic Acid Phosphatase/ACPP
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
Marke: R&D Systems™ 6240-AP-010
399.13 CHF gültig bis 2024-12-16
Benutzen Sie den Promotions-Code "21630" um Ihren Promotions-Preis zu erhalten.
Dieser Artikel kann nicht zurückgegeben werden.
Rückgaberichtlinie anzeigen
Beschreibung
Measured by its ability to cleave a substrate, p-Nitrophenyl phosphate (pNPP). The specific activity is >100,000 pmol/min/ug, as measured under the described conditions.Spezifikation
P15309 | |
Supplied as a 0.2 μm filtered solution in Tris and NaCl. | |
M.W. (Observed): 43-55 kDa, reducing conditions; M.W. (theoretical): 41 kDa | |
10 μg | |
Do not freeze. 3 months from date of receipt, 2°C to 8°C as supplied. 1 month, 2°C to 8°C under sterile conditions after opening. | |
ACPP | |
Recombinant | |
Prostatic Acid Phosphatase/ACPP |
Enzyme Activity | |
55 | |
Prostatic Acid Phosphatase/ACPP | |
Mouse myeloma cell line, NS0-derived human Prostatic Acid Phosphatase/ACPP protein Met1-Gln379, with a C-terminal 6-His tag | |
<1.0 EU / 1 μg of the protein by the LAL method. | |
Unconjugated | |
>95%, by SDS-PAGE under reducing conditions and visualized by Colloidal Coomassie™ Blue stain (at 5 μg / lane) |